Synapse

← Expert Review of Precision Medicine and Drug Development

Papers in Expert Review of Precision Medicine and Drug Development

Page 3 · newest first

  1. Recent advances towards gene therapy for propionic acidemia: translation to the clinicExpert Review of Precision Medicine and Drug Development · 2019
  2. Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine TrialExpert Review of Precision Medicine and Drug Development · 2019
  3. Precision medicine for the treatment of sepsis: recent advances and future prospectsExpert Review of Precision Medicine and Drug Development · 2019
  4. New treatment targets in multiple sclerosis therapyExpert Review of Precision Medicine and Drug Development · 2019
  5. Use of big data in drug development for precision medicine: an updateExpert Review of Precision Medicine and Drug Development · 2019
  6. Gilteritinib for the treatment of patients withFLT3mutated relapsed or refractory acute myeloid leukemiaExpert Review of Precision Medicine and Drug Development · 2019
  7. Advances in precision epigenetic treatment for acute promyelocytic leukemia.Expert Review of Precision Medicine and Drug Development · 2019
  8. Novel therapeutic targets and drug development for the precision treatment of COPDExpert Review of Precision Medicine and Drug Development · 2019
  9. Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeuticsExpert Review of Precision Medicine and Drug Development · 2019
  10. An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancerExpert Review of Precision Medicine and Drug Development · 2019
  11. Deep learning and radiomics in precision medicineExpert Review of Precision Medicine and Drug Development · 2019
  12. Privacy and ethical challenges in next-generation sequencingExpert Review of Precision Medicine and Drug Development · 2019
  13. Precision therapy in advanced urothelial cancerExpert Review of Precision Medicine and Drug Development · 2019
  14. Development pathways for subcutaneous formulations of biologics versus biosimilar developmentExpert Review of Precision Medicine and Drug Development · 2019
  15. Recent advances in precision medicine for the treatment of anaplastic thyroid cancerExpert Review of Precision Medicine and Drug Development · 2019
  16. Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumorsExpert Review of Precision Medicine and Drug Development · 2019
  17. Emerging DNA methylation inhibitors for cancer therapy: challenges and prospectsExpert Review of Precision Medicine and Drug Development · 2019
  18. The potential of genotype-guided antiplatelet therapy: promises and challengesExpert Review of Precision Medicine and Drug Development · 2018
  19. The potential of precision medicine for childhood acute lymphoblastic leukemia: opportunities and challengesExpert Review of Precision Medicine and Drug Development · 2018
  20. Modulating the cystic fibrosis transmembrane regulator and the development of new precision drugsExpert Review of Precision Medicine and Drug Development · 2018
  21. Leaving some behind: the growing gap in precision medicine for minority populationsExpert Review of Precision Medicine and Drug Development · 2018
  22. Big data, artificial intelligence, and cardiovascular precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  23. Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failureExpert Review of Precision Medicine and Drug Development · 2018
  24. Lessons in practicing cancer genomics and precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  25. Personalizing the approach to asthma treatmentExpert Review of Precision Medicine and Drug Development · 2018
  26. The value of genetic risk scores in precision medicine for diabetesExpert Review of Precision Medicine and Drug Development · 2018
  27. Precision medicine for age-related macular degeneration: current developments and prospectsExpert Review of Precision Medicine and Drug Development · 2018
  28. Personalized treatment in the epilepsies: challenges and opportunitiesExpert Review of Precision Medicine and Drug Development · 2018
  29. Population-level pharmacogenomics for precision drug development in dementiaExpert Review of Precision Medicine and Drug Development · 2018
  30. Overcoming diagnostic issues in precision treatment of pancreatic cancerExpert Review of Precision Medicine and Drug Development · 2018
  31. TRAIL pathway targeting therapeuticsExpert Review of Precision Medicine and Drug Development · 2018
  32. The interaction between vitamin C and bone health: a narrative reviewExpert Review of Precision Medicine and Drug Development · 2018
  33. Immunotherapy and next-generation sequencing guided therapy for precision oncology: what have we learnt and what does the future hold?Expert Review of Precision Medicine and Drug Development · 2018
  34. Tailored approaches to rare sarcomas: current challenges and future prospectsExpert Review of Precision Medicine and Drug Development · 2018
  35. ‘You-on-a-chip’ for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  36. Progress towards precision medicine for lupus: the role of genetic biomarkersExpert Review of Precision Medicine and Drug Development · 2018
  37. Cystic fibrosis: a model for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  38. PARP inhibitors and breast cancer: highlights and hang-upsExpert Review of Precision Medicine and Drug Development · 2018
  39. Microbes in food to treat and prevent diseaseExpert Review of Precision Medicine and Drug Development · 2018
  40. The economic case for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  41. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatmentExpert Review of Precision Medicine and Drug Development · 2018
  42. The role for rapid molecular diagnostic tests for infectious diseases in precision medicineExpert Review of Precision Medicine and Drug Development · 2018
  43. Drug repositioning: current approaches and their implications in the precision medicine eraExpert Review of Precision Medicine and Drug Development · 2018
  44. RET rearrangements in non–small cell lung cancer and implications for the future of precision drug developmentExpert Review of Precision Medicine and Drug Development · 2018
  45. Circulating tumor DNA: an important tool in precision medicine for lymphomaExpert Review of Precision Medicine and Drug Development · 2017
  46. Midostaurin and emerging FLT3 inhibitors for the treatment of adults with newly diagnosed acute myeloid leukemia with the FLT3 mutationExpert Review of Precision Medicine and Drug Development · 2017
  47. Integrating pharmacogenetic testing into primary careExpert Review of Precision Medicine and Drug Development · 2017
  48. Personalized peptide vaccines for cancer therapy: current progress and state of the artExpert Review of Precision Medicine and Drug Development · 2017
  49. Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision makingExpert Review of Precision Medicine and Drug Development · 2017
  50. Biosensors and personalized drug therapy: what does the future hold?Expert Review of Precision Medicine and Drug Development · 2017